(Q41467769)

1 October 2017

1 reference

title

Reductive activation of nitroheterocyclic compounds (English)

1 reference

1 October 2017

Tocher JH

1

1 reference

1 October 2017

publication date

1 April 1997

1 reference

1 October 2017

1 reference

1 October 2017

volume

28

1 reference

1 October 2017

issue

4

1 reference

1 October 2017

page(s)

485-487

1 reference

The novel fluorinated 2-nitroimidazole hypoxia probe SR-4554: reductive metabolism and semiquantitative localisation in human ovarian cancer multicellular spheroids as measured by electron energy loss spectroscopic analysis

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900283-2

7 January 2021

Hypoxia-mediated nitro-heterocyclic drugs in the radio- and chemotherapy of cancer. An overview

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900283-2

7 January 2021

A review of hypoxic cell radiosensitization.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900283-2

7 January 2021

Reduction of nitroimidazoles in vitro and DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900283-2

7 January 2021

Nitroimidazole drugs-action and resistance mechanisms I. Mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900283-2

7 January 2021

Nitroimidazole drugs--action and resistance mechanisms. II. Mechanisms of resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900283-2

7 January 2021

Structure-cytotoxicity relationships of nitroimidazoles in an in vitro system

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900283-2

7 January 2021

Radicals of nitroimidazole derivatives: pH dependence of rates of formation and decay related to acid-base equilibria

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900283-2

7 January 2021

Nitro group orientation, reduction potential, and direct-acting mutagenicity of nitro-polycyclic aromatic hydrocarbons

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900283-2

7 January 2021

The metabolic activation of nitroheterocyclic therapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900283-2

7 January 2021

Interaction of nitroimidazole drugs with DNA in vitro: structure-activity relationships

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900283-2

7 January 2021

The mechanism of nitroimidazole damage to DNA: coulometric evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900283-2

7 January 2021

Reductive chemistry of the novel hypoxia-selective cytotoxin 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900283-2

7 January 2021

Quantitative Structure-Activity Relationships for Antimicrobial Nitroheterocyclic Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900283-2

7 January 2021

Molecular basis of chloramphenicol and thiamphenicol toxicity to DNA in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900283-2

7 January 2021

The influence of microaerophilia and anaerobiosis on metronidazole uptake in Helicobacter pylori.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900283-2

7 January 2021

Electrochemical characteristics of nitroheterocyclic compounds of biological interest. V. Measurement and comparison of nitro radical lifetimes

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900283-2

7 January 2021

Evidence for the direct interaction of reduced metronidazole derivatives with DNA bases

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900283-2

7 January 2021

Electrochemical characteristics of nitro-heterocyclic compounds of biological interest. II. Nitrosochloramphenicol

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900283-2

7 January 2021

On the mutagenicity of nitroimidazoles

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900283-2

7 January 2021

RTOG's first quality of life study—RTOG 90-20: A phase II trial of external beam radiation with etanidazole for locally advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2896%2900283-2

7 January 2021

10.1016/S0306-3623(96)00283-2

Identifiers

DOI

1 reference

1 October 2017

1 reference